Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 17
Final Report of the National Academies’ Human Embryonic Stem Cell Research Advisory Committee and 2010 Amendments to the National Academies’ Guidelines for Human Embryonic Stem Cell Research Appendix B Invited Participants at the August 7, 2009, Meeting of the Human Embryonic Stem Cell Research Advisory Committee GEORGE Q. DALEY, Samuel E. Lux IV Chair in Hematology and Director, Stem Cell Transplantation Program, Children’s Hospital Boston; Associate Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; Investigator, Howard Hughes Medical Institute; and Past President, International Society for Stem Cell Research DEBORAH A. HURSH, Senior Investigator, Division of Cellular and Gene Therapies, Center for Biologics Research and Review, U.S. Food and Drug Administration JULIE KANESHIRO, Team Leader, Policy, Office for Human Research Protections, Department of Health and Human Services STORY LANDIS, Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), and Chair, NIH Stem Cell Task Force BERNARD LO, Professor of Medicine and Director of the Program in Medical Ethics, University of California, San Francisco GEOFF LOMAX, Senior Officer to the Standards Working Group, California Institute for Regenerative Medicine
OCR for page 18
Final Report of the National Academies’ Human Embryonic Stem Cell Research Advisory Committee and 2010 Amendments to the National Academies’ Guidelines for Human Embryonic Stem Cell Research JOHN MCNEISH, Executive Director, Pfizer Regenerative Medicine P. PEARL O’ROURKE, Director of Human Research Affairs, Partners HealthCare System, Boston; and Associate Professor of Pediatrics, Harvard Medical School SEAN TIPTON, Past-President, Coalition for the Advancement of Medical Research; and Director of Public Affairs, American Society for Reproductive Medicine